GCM
PHVS icon

Ghisallo Capital Management’s Pharvaris PHVS Stock Holding History

Ghisallo Capital Management’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,249
Closed -$208K – 150
2024
Q3 		$208K Buy
+11,249
New +$206K 0.01% 142

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Ghisallo Capital Management's PHVS Position: Q4 2024 in Review

Ghisallo Capital Management sold out of Pharvaris (PHVS) in Q4 2024, closing a stake of 11,249 shares — an estimated $208K sold.

Ghisallo Capital Management first reported a position in PHVS in Q3 2024 and held it in 1 quarter. The position peaked at $208K in Q3 2024. 54 funds tracked by Wall St. Rank hold PHVS as of Q4 2024.

  • Ghisallo Capital Management reported no remaining Pharvaris position as of Q4 2024 after selling out during the quarter.
  • Ghisallo Capital Management sold 11,249 Pharvaris shares in Q4 2024, an estimated $208K.
  • Ghisallo Capital Management first reported a position in Pharvaris in Q3 2024 and held it in 1 quarter.
  • Ghisallo Capital Management's Pharvaris position peaked at $208K in Q3 2024.
  • 54 funds tracked by Wall St. Rank held Pharvaris as of Q4 2024.

Based on Ghisallo Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.